CareDx, Inc. (CDNA)
76.33
-9.53
(-11.10%)
USD |
NASDAQ |
Nov 05, 16:00
75.35
-0.98
(-1.28%)
After-Hours: 20:00
CareDx Cash from Investing (Quarterly) : -147.88M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -147.88M |
| June 30, 2026 | 280.59M |
| March 31, 2026 | 11.06M |
| December 31, 2025 | -34.91M |
| September 30, 2025 | 12.35M |
| June 30, 2025 | 23.40M |
| March 31, 2025 | 1.325M |
| December 31, 2024 | -2.111M |
| September 30, 2024 | -14.41M |
| June 30, 2024 | -11.63M |
| March 31, 2024 | 27.66M |
| December 31, 2023 | 41.37M |
| September 30, 2023 | -1.498M |
| June 30, 2023 | 15.35M |
| March 31, 2023 | -14.77M |
| December 31, 2022 | 2.475M |
| September 30, 2022 | -75.74M |
| June 30, 2022 | 0.79M |
| March 31, 2022 | -156.03M |
| December 31, 2021 | -7.782M |
| September 30, 2021 | 20.20M |
| June 30, 2021 | 16.21M |
| March 31, 2021 | 19.08M |
| December 31, 2020 | -90.47M |
| September 30, 2020 | -4.236M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.98M |
| March 31, 2020 | -1.704M |
| December 31, 2019 | -1.342M |
| September 30, 2019 | -3.515M |
| June 30, 2019 | -17.18M |
| March 31, 2019 | -0.543M |
| December 31, 2018 | -0.96M |
| September 30, 2018 | -0.614M |
| June 30, 2018 | -5.601M |
| March 31, 2018 | -0.754M |
| December 31, 2017 | -5.061M |
| September 30, 2017 | -1.009M |
| June 30, 2017 | 0.01M |
| March 31, 2017 | -0.104M |
| December 31, 2016 | 0.077M |
| September 30, 2016 | -0.351M |
| June 30, 2016 | -20.73M |
| March 31, 2016 | -0.109M |
| December 31, 2015 | -0.076M |
| September 30, 2015 | -0.39M |
| June 30, 2015 | -0.369M |
| March 31, 2015 | -0.364M |
| December 31, 2014 | -0.594M |
| September 30, 2014 | -0.199M |
| June 30, 2014 | -0.521M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Natera, Inc. | -63.43M |
| Myriad Genetics, Inc. | -2.10M |
| BioRestorative Therapies, Inc. | 0.9684M |
| Exagen, Inc. | -0.543M |
| Sera Prognostics, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 12.72M |
| Cash from Financing (Quarterly) | 12.90M |
| Free Cash Flow | 59.76M |
| Free Cash Flow Per Share (Quarterly) | 0.2019 |
| Free Cash Flow to Equity (Quarterly) | 1.349M |
| Free Cash Flow to Firm (Quarterly) | 11.10M |
| Free Cash Flow Yield | 1.47% |